[
  {
    "ts": "2025-12-04T13:00:00+00:00",
    "headline": "Sudo Biosciences Appoints Paul Bavier as Chief Legal Counsel",
    "summary": "CARMEL, Ind. & LONDON, December 04, 2025--Sudo Biosciences Appoints Paul Bavier as Chief Legal Counsel",
    "url": "https://finance.yahoo.com/news/sudo-biosciences-appoints-paul-bavier-130000969.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "3f432455-8cd3-3d07-b1a1-38625c53586a",
      "content": {
        "id": "3f432455-8cd3-3d07-b1a1-38625c53586a",
        "contentType": "STORY",
        "title": "Sudo Biosciences Appoints Paul Bavier as Chief Legal Counsel",
        "description": "",
        "summary": "CARMEL, Ind. & LONDON, December 04, 2025--Sudo Biosciences Appoints Paul Bavier as Chief Legal Counsel",
        "pubDate": "2025-12-04T13:00:00Z",
        "displayTime": "2025-12-04T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/0be4145aae162f11d67f14b327351b15",
          "originalWidth": 480,
          "originalHeight": 232,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/58cSIxPDc88koJK.o1JRQw--~B/aD0yMzI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/0be4145aae162f11d67f14b327351b15.cf.webp",
              "width": 480,
              "height": 232,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KWrhONojUojenAKT0UVsmA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/0be4145aae162f11d67f14b327351b15.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sudo-biosciences-appoints-paul-bavier-130000969.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sudo-biosciences-appoints-paul-bavier-130000969.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HLVX"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "GKOS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-04T17:05:00+00:00",
    "headline": "FDA Conditionally Approves Merck Animal Health's EXZOLT™ CATTLE-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (myiasis)",
    "summary": "RAHWAY, N.J., December 04, 2025--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug Administration (FDA) has granted a conditional approval for EXZOLT™ CATTLE-CA1 (fluralaner topical solution). This innovative product is in the newest class of parasiticides known as isoxazolines. The pour-on solution is effective for the prevention and treatment of infestati",
    "url": "https://finance.yahoo.com/news/fda-conditionally-approves-merck-animal-170500118.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "4c72bd1f-269d-38ae-af64-6cb934d89c23",
      "content": {
        "id": "4c72bd1f-269d-38ae-af64-6cb934d89c23",
        "contentType": "STORY",
        "title": "FDA Conditionally Approves Merck Animal Health's EXZOLT™ CATTLE-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (myiasis)",
        "description": "",
        "summary": "RAHWAY, N.J., December 04, 2025--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug Administration (FDA) has granted a conditional approval for EXZOLT™ CATTLE-CA1 (fluralaner topical solution). This innovative product is in the newest class of parasiticides known as isoxazolines. The pour-on solution is effective for the prevention and treatment of infestati",
        "pubDate": "2025-12-04T17:05:00Z",
        "displayTime": "2025-12-04T17:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/9856c674e38f632a6b442059ce19f666",
          "originalWidth": 480,
          "originalHeight": 240,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/T4FZIUxEymZhIdGTwy17cA--~B/aD0yNDA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/9856c674e38f632a6b442059ce19f666.cf.webp",
              "width": 480,
              "height": 240,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/94as0axJ8PHziHVKAwI9yg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/9856c674e38f632a6b442059ce19f666.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/fda-conditionally-approves-merck-animal-170500118.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fda-conditionally-approves-merck-animal-170500118.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-04T16:10:00+00:00",
    "headline": "The Biotech Industry Is Healthier Than Investors Think. These Are the Stocks to Watch.",
    "summary": "RA Capital Management’s Peter Kolchinsky says the companies that survived the industry’s 2021 rout are thriving—and looking to make deals.",
    "url": "https://www.barrons.com/articles/biotech-stocks-deals-mergers-acquisitions-8c94d042?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "aa41dce1-63e1-3f61-9a06-de0c5bc81971",
      "content": {
        "id": "aa41dce1-63e1-3f61-9a06-de0c5bc81971",
        "contentType": "STORY",
        "title": "The Biotech Industry Is Healthier Than Investors Think. These Are the Stocks to Watch.",
        "description": "",
        "summary": "RA Capital Management’s Peter Kolchinsky says the companies that survived the industry’s 2021 rout are thriving—and looking to make deals.",
        "pubDate": "2025-12-04T16:10:00Z",
        "displayTime": "2025-12-04T16:10:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/aa41dce1-63e1-3f61-9a06-de0c5bc81971/the-biotech-industry-is.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/a3fb83393145973b44a1be926982d16c",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dVux.MPXQPqDkmkukwdh8g--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/a3fb83393145973b44a1be926982d16c.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Td.M9HlJvbijYNhUX8Wxbw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/a3fb83393145973b44a1be926982d16c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/biotech-stocks-deals-mergers-acquisitions-8c94d042?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CDTX"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "RYTM"
            },
            {
              "symbol": "ASND"
            },
            {
              "symbol": "XBI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-04T18:26:00+00:00",
    "headline": "Halozyme Wins Preliminary Injunction Against Merck's Keytruda SC in Germany",
    "summary": "Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme), announced today that a German court has granted its request for a preliminary injunction ordering Merck to refrain from distributing and offering Keytruda SC in Germany.",
    "url": "https://finance.yahoo.com/news/halozyme-wins-preliminary-injunction-against-182600540.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "55e033f0-3a7f-355d-a06f-201645e959a9",
      "content": {
        "id": "55e033f0-3a7f-355d-a06f-201645e959a9",
        "contentType": "STORY",
        "title": "Halozyme Wins Preliminary Injunction Against Merck's Keytruda SC in Germany",
        "description": "",
        "summary": "Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme), announced today that a German court has granted its request for a preliminary injunction ordering Merck to refrain from distributing and offering Keytruda SC in Germany.",
        "pubDate": "2025-12-04T18:26:00Z",
        "displayTime": "2025-12-04T18:26:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/c2d10463941059496c22a9967916bfb1",
          "originalWidth": 400,
          "originalHeight": 167,
          "caption": "Halozyme Therapeutics, Inc. Logo. (PRNewsFoto/Halozyme Therapeutics, Inc.) (PRNewsfoto/Halozyme Therapeutics, Inc.)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/g75kczZcd5MaZJYqyjNiSg--~B/aD0xNjc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/c2d10463941059496c22a9967916bfb1.cf.webp",
              "width": 400,
              "height": 167,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/So_e66wwLJmH4i1xsBBqvA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/c2d10463941059496c22a9967916bfb1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/halozyme-wins-preliminary-injunction-against-182600540.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/halozyme-wins-preliminary-injunction-against-182600540.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HALO"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-04T16:20:00+00:00",
    "headline": "Can Merck's New Products Aid Growth as Keytruda LOE Test Looms?",
    "summary": "MRK banks on Capvaxive, Winrevair and other new launches to counter Keytruda's looming 2028 LOE and record long-term growth.",
    "url": "https://finance.yahoo.com/news/mercks-products-aid-growth-keytruda-162000136.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "802086c1-cf2d-37e7-9e26-f936354f22ea",
      "content": {
        "id": "802086c1-cf2d-37e7-9e26-f936354f22ea",
        "contentType": "STORY",
        "title": "Can Merck's New Products Aid Growth as Keytruda LOE Test Looms?",
        "description": "",
        "summary": "MRK banks on Capvaxive, Winrevair and other new launches to counter Keytruda's looming 2028 LOE and record long-term growth.",
        "pubDate": "2025-12-04T16:20:00Z",
        "displayTime": "2025-12-04T16:20:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/df847a6f57145ec8b42be7c65f980057",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EfDoN3QVRYGCfRDweFAACw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/df847a6f57145ec8b42be7c65f980057.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JwDxubmjtiCRyiYBqVh9AQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/df847a6f57145ec8b42be7c65f980057.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/mercks-products-aid-growth-keytruda-162000136.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/mercks-products-aid-growth-keytruda-162000136.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-04T18:58:22+00:00",
    "headline": "Merck & Co., Inc. (MRK): A Bull Case Theory",
    "summary": "We came across a bullish thesis on Merck & Co., Inc. on Darius Dark Investing’s Substack. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc.’s share was trading at $101.03 as of December 2nd. MRK’s trailing and forward P/E were 13.47 and 10.83 respectively according to Yahoo Finance. Merck & Co. (MRK) […]",
    "url": "https://finance.yahoo.com/news/merck-co-inc-mrk-bull-185822953.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "a2d2981f-ebcd-34e0-b65d-b126fd9b8518",
      "content": {
        "id": "a2d2981f-ebcd-34e0-b65d-b126fd9b8518",
        "contentType": "STORY",
        "title": "Merck & Co., Inc. (MRK): A Bull Case Theory",
        "description": "",
        "summary": "We came across a bullish thesis on Merck & Co., Inc. on Darius Dark Investing’s Substack. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc.’s share was trading at $101.03 as of December 2nd. MRK’s trailing and forward P/E were 13.47 and 10.83 respectively according to Yahoo Finance. Merck & Co. (MRK) […]",
        "pubDate": "2025-12-04T18:58:22Z",
        "displayTime": "2025-12-04T18:58:22Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/91d6221e3df11e4933938a3082c41da1",
          "originalWidth": 949,
          "originalHeight": 505,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qbitK_60Vc8oncBc9nQEQw--~B/aD01MDU7dz05NDk7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/91d6221e3df11e4933938a3082c41da1.cf.webp",
              "width": 949,
              "height": 505,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wtjhuWw_GHJ65_98O46.rg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/91d6221e3df11e4933938a3082c41da1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/merck-co-inc-mrk-bull-185822953.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-co-inc-mrk-bull-185822953.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]